In the EGFR gene, for example, we detected L858R (in II-18 and H1975) and E746_A750del mutations (in PC-9 and H1650), which are known to be sensitive to the anti-cancer drugs, gefitinib and erlotinib. This evidence concerns the gene EGFR and cancer.